These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6531058)

  • 21. [Predictive value of lithogenic risk in hypercalciuria: should 24-hour urine calcium be measured?].
    Ulmann A
    Nephrologie; 1984; 5(5):232-4. PubMed ID: 6531063
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Study of crystalluria in diabetic patients].
    Mbarki M; Jabrane J; Oussama A; Daudon M
    Prog Urol; 2005 Jun; 15(3):420-5; discussion 425-6. PubMed ID: 16097146
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized trial of allopurinol in the prevention of calcium oxalate calculi.
    Ettinger B; Tang A; Citron JT; Livermore B; Williams T
    N Engl J Med; 1986 Nov; 315(22):1386-9. PubMed ID: 3534570
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical experience with low dosage of propionohydroxamic acid (PHA) in infected renal stones.
    Martelli A; Buli P; Spatafora S
    Urology; 1986 Nov; 28(5):373-5. PubMed ID: 3787895
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Formation of a single calcium stone of renal origin. Clinical and laboratory characteristics of patients.
    Strauss AL; Coe FL; Parks JH
    Arch Intern Med; 1982 Mar; 142(3):504-7. PubMed ID: 7065787
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Physiological and physiochemical correction and prevention of calcium stone formation by potassium citrate therapy.
    Pak CY; Sakhaee K; Fuller CJ
    Trans Assoc Am Physicians; 1983; 96():294-305. PubMed ID: 6679957
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of oral purine load and allopurinol on the crystallization of calcium salts in urine of patients with hyperuricosuric calcium urolithiasis.
    Pak CY; Barilla DE; Holt K; Brinkley L; Tolentino R; Zerwekh JE
    Am J Med; 1978 Oct; 65(4):593-9. PubMed ID: 707519
    [No Abstract]   [Full Text] [Related]  

  • 28. Allopurinol treatment of uric-acid disorders in calcium-stone formers.
    Coe FL; Raisen L
    Lancet; 1973 Jan; 1(7795):129-31. PubMed ID: 4118468
    [No Abstract]   [Full Text] [Related]  

  • 29. Oxypurinol nephrolithiasis in regional enteritis secondary to allopurinol therapy.
    Stote RM; Smith LH; Dubb JW; Moyer TP; Alexander F; Roth JL
    Ann Intern Med; 1980 Mar; 92(3):384-5. PubMed ID: 7356232
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitation of response to therapy in calcium urolithiasis.
    Zerwekh JE; Lawoyin O; Pak CY
    Urol Res; 1979 Sep; 7(3):209-13. PubMed ID: 388797
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Symposium on renal lithiasis. Medical aspects of renal calculous disease. Treatment and prophylaxis.
    Thomas WC
    Urol Clin North Am; 1974 Jun; 1(2):261-78. PubMed ID: 4610943
    [No Abstract]   [Full Text] [Related]  

  • 32. Medical and dietary therapy for kidney stone prevention.
    Gul Z; Monga M
    Korean J Urol; 2014 Dec; 55(12):775-9. PubMed ID: 25512810
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prevention of urinary calculi with thiazides and allopurinol. A long-term study].
    May P; Pilorz H; Duhme C; Pöpperl H; Braun J
    Urologe A; 1984 Mar; 23(2):87-90. PubMed ID: 6426113
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Uric acid nephrolithiasis.
    Halabe A; Sperling O
    Miner Electrolyte Metab; 1994; 20(6):424-31. PubMed ID: 7783706
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Influence of urinary citrate levels on spontaneous calcium oxalate dihydrate crystalluria].
    Hassani MA; Hennequin C; Lacour B; Daudon M
    Prog Urol; 2005 Sep; 15(4):650-5. PubMed ID: 16459680
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Compared metabolic effects of phosphorus or hydrochlorothiazide therapy in hypercalciuric stone-formers (author's transl)].
    Dard S; Ulmann A
    Nephrologie; 1981; 2(1):4-7. PubMed ID: 7345375
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [When does allopurinol treatment fail in recurring calcium lithiasis?].
    Ulshöfer B; Kiechle J
    Helv Chir Acta; 1985 Sep; 52(3-4):499-502. PubMed ID: 4066382
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical characteristics and pathogenetic mechanisms in hyperuricosuric calcium oxalate renal stone disease.
    Favus MJ; Coe FL
    Scand J Urol Nephrol Suppl; 1980; 53():171-7. PubMed ID: 6937993
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathophysiologic basis for normouricosuric uric acid nephrolithiasis.
    Sakhaee K; Adams-Huet B; Moe OW; Pak CY
    Kidney Int; 2002 Sep; 62(3):971-9. PubMed ID: 12164880
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Randomized prospective study of a nonthiazide diuretic, indapamide, in preventing calcium stone recurrences.
    Borghi L; Meschi T; Guerra A; Novarini A
    J Cardiovasc Pharmacol; 1993; 22 Suppl 6():S78-86. PubMed ID: 7508066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.